Summary
No overall score for this company yet.
Valuation -Growth -Profitability -Quality 24Debt 0Stability 20
What speaks for it
None of the indicators we track stands out on the positive side.
What to watch
- It passes only 1 of the 9 points of the Piotroski financial health test.
- For every 100 CAD of bills due within a year it has 0.2 CAD of short-term assets.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Is it growing?
Revenue (CAD)
20192020202120222023
Diluted EPS (CAD)
20192020202120222023
There is not enough revenue history yet to say how fast it grows.
Growth in detailDoes it make money?
Income figures for the last 12 months are not available.
Profitability in detailIs it financially healthy?
Cash and short-term investments $2.54K
Debt $8.45M
Its debt is larger than its cash.
Financial health in detailDoes it pay a dividend?
NoIt pays no dividend.
Dividends in detailWhat do analysts expect?
No coverageNo analyst covers this stock.
Analysts in detailWhat does it earn on?
By product
The company reports no revenue by product.
By region
The company reports no revenue by region.